Sponsor pipeline

Ascentage Pharma Group Inc. clinical trial pipeline

Get alerts when Ascentage Pharma Group Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
11
Phase 1/2
6
Phase 2
2
Phase 3
7

Disease areas by active trials, top 10 of 18

Leukemia (14) · Chronic Lymphocytic Leukemia (CLL) (7) · Acute Myeloid Leukemia (AML) (3) · Non-Hodgkin Lymphoma (3) · Acute Lymphoblastic Leukemia (ALL) (2) · Chronic Myeloid Leukemia (CML) (2) · Lung Cancer (2) · Myelodysplastic Syndromes (MDS) (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Ovarian Cancer (2)

Get alerts when Ascentage Pharma Group Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free